MeSH Browser

MeSH Heading: Sildenafil Citrate
Tree Number(s): D02.065.884.675; D02.886.590.700.675; D03.383.606.854; D03.633.100.759.824
Unique ID: D000068677
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000068677
Scope Note: A PHOSPHODIESTERASE TYPE-5 INHIBITOR; VASODILATOR AGENT and UROLOGICAL AGENT that is used in the treatment of ERECTILE DYSFUNCTION and PRIMARY PULMONARY HYPERTENSION.
Entry Term(s): 1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate; Acetildenafil; Desmethyl Sildenafil; Desmethylsildenafil; Homosildenafil; Hydroxyhomosildenafil; NCX-911; Revatio; Sildenafil; Sildenafil Lactate; Sildenafil Nitrate; UK 92480-10; UK-92,480-10; Viagra
Pharm Action: Vasodilator Agents
Phosphodiesterase 5 Inhibitors
Urological Agents
Related Numbers: 0Z3JH0S0QK; 139755-83-2; 3M7OB98Y7H; 80X7B1F6NW; L6WO34R9YG; TP0E2BW57H
See Also: Tadalafil
Public MeSH Note: 2016; SILDENAFIL CITRATE was indexed under PIPERAZINES; PURINES; and under SULFONAMIDES 1997-2015
History Note: 2016 (1997)
Date Established: 2016/01/01
Date of Entry: 2015/07/10
Revision Date: 2016/05/31

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Sildenafil Citrate MeSH Descriptor Data 2025